ANYGEN CO., LTD. is a biotechnology company based in Korea South, founded in 2000. The company's slogan, "Synthesizing Therapeutic Future," reflects its commitment to developing cutting-edge therapeutic solutions. ANYGEN specializes in supplying high-quality peptides using advanced synthesis technology and extensive industry experience.
The company operates within the biotechnology, health care, and manufacturing industries. Its dedication to prompt delivery of various types of peptides has attracted notable investors, including Solidus Investment and Hyundai Venture Investment Corporation. The last venture round investment occurred on 01 January 2014, indicating potential growth and development opportunities.
No recent news or press coverage available for ANYGEN CO., LTD..